February 28, 2023

EPR at BPS2023 – A (Magnetic) Field of Opportunity

Despite being still an incredibly niche technique, the current state of EPR is something to be excited about. EPR – electron paramagnetic resonance – is a diverse and robust technique that can unlock biophysical information by measuring nanoscale intramolecular distances, determining localized dynamics, and probing paramagnetic binding environments. Every year talented investigators are using this spectroscopy to discover new information and solve old problems. I had the chance to interact with several such groups and see firsthand the new directions the field is heading.

Prof. Indra Sahu (Campbellsville University) applied EPR distance methodologies to the KCNE3 membrane protein within a lipid bilayer. These distance measurements were used in conjunction with an existing NMR solution structure of this system, to provide a better understanding of the protein’s structure in its native physiological environment. These results were complemented by a series of dynamical measurements by CW-EPR (continuous wave EPR) used to further characterize the topology of the protein.

Additionally, Prof. Candice Klug’s group (Wisconsin Medical School) presented a study of CW-EPR dynamics measurements in the activation loop of a transmembrane kinase, IreK. This protein is involved in certain drug resistances in many bacteria, and the activation loop studied here is thought to be involved in regulating IreK’s activity. Such flexible and dynamic structures are difficult to resolve through crystallization, NMR, or CryoEM. Understanding the dynamics of this loop via EPR furthers our understanding of antibiotic resistance mechanisms, a critical consideration in modern pharmacology.

I was also impressed with a bevy of EPR distance constraints used to characterize membrane transport protein ApcT, presented by Prof. Kelli Kazmier (Hillsdale College). These measurements demonstrated pH-dependent conformational shifts, as well as provided insights into the conformations themselves. As membrane proteins are an incredibly important class of biomolecules, responsible for intercellular communication and messaging, ion transport, and are a huge target for drug development, these bodies of work present an excellent example of the power of modern EPR.

Beyond just exciting developments in EPR, this year’s BPS meeting was full of interesting science and rife with opportunities for EPR to step up. Amid many hot topics, intrinsically disordered proteins (IDPs) are a promising category of biomolecules that could benefit from the magnetic touch of EPR. Prof. Jane Dyson (Scripps) and Prof. Elizabeth Komives (UCSD) spoke at length on the relationship between such disorder and its function – specifically on a tumor suppressor and transcription regulator protein, respectively. The characteristic dynamism and flexibility of such biomolecules make them difficult to resolve through traditional means, and therefore they make an enticing target for further complementary EPR study.

In another session, Prof. Ryan Hibbs (UT Southwestern/UCSD) presented on gating mechanisms of an acetylcholine receptor derived from a torpedo ray. Amidst some impressive CryoEM structures, he noted a major bottleneck in this work is that structures have been solved only for the protein’s resting and desensitized state and that the active state structure is unknown. This problem derives from the short lifespan of the activated state of the protein, and the difficulty of catching such a dynamic snapshot by crystallization, CryoEM, or NMR. EPR’s ability to distinguish conformations within an ensemble of states – coupled with careful sample preparation, flash-freezing, and structural modeling – could be used to access structural information on such difficult problems.

BPS2023 was a great way to kick off the conference circuit at High Q this year. There was some excellent work in the field of EPR, but perhaps more importantly, there was a world of problems and applications we believe we can help solve. In thinking back to that first CryoEM session, such a moment may seem mundane in the current scientific landscape but even just a few years ago the answer to ‘who has prepared a CryoEM grid?’ may have been staggeringly different. I can see the opportunity for EPR to make its mark, where the question ‘who has prepared a sample for EPR’ may be met with similar results.

We have an exciting year ahead, and many more great conversations to have to with the scientific community. Our next stop – the Royal Society of Chemistry ESR Meeting. See you in Leeds!

Our News

Related posts

Explore Insights
How to Validate Protein Dimerization Using DEER EPR, AUC, and SEC-MALS
How to Validate Protein Dimerization Using Electron Paramagnetic Resonance

Protein dimerization is one of the most widespread and functionally important forms of protein–protein interaction. Proteins rarely act in isolation in a biological environment; instead, they associate as homodimers, heterodimers or higher-order oligomers to form functional assemblies. This self-assembly occurs in every cellular compartment, from membranes to the nucleus and cytosol, and regulates processes ranging from enzymatic activation and signal transduction to pathogenic pathways. A dimer observed in a crystal structure, however, may represent either a genuine biological assembly or a contact created by crystal packing. A crystal structure provides detailed information about molecular architecture, but it does not by itself establish whether two molecules associate under relevant solution conditions, how strong that interaction is, or whether the subunits retain the same arrangement outside the lattice. Distinguishing between these possibilities is therefore an important task in structural biology, biophysics and pharmaceutical research, where protein–protein interactions can influence function, stability and the binding of potential drug candidates.

Read article
How to Validate Protein Dimerization Using Electron Paramagnetic Resonance
Protein Dimerization: Is your crystal structure dimer real? Testing protein dimers in solution
Protein Dimerization: Is your crystal structure dimer real?

Protein dimerization occurs when two protein molecules associate to form a dimer. A crystal structure can reveal how two protein molecules fit together, identifying an interface that may influence protein function or drug discovery. However, a dimer observed in a crystal does not necessarily represent the dominant assembly in solution. Crystal packing can stabilize contacts that are weak, transient, or absent under physiologically relevant conditions. For pharmaceutical researchers, this distinction matters because a proposed dimer interface may form a binding site, regulate protein activity, or provide a target for small molecules. Before using the structure to guide drug design, researchers need to establish whether the protein associates in solution and whether the arrangement of its subunits is consistent with the proposed model.

Read article
Protein Dimerization: Is your crystal structure dimer real?
AlphaFold-and-EPR-Spectroscopy: Partners to Understand Protein Structure, Dynamics and Function
AlphaFold and EPR Spectroscopy: Complementary Tools for Understanding Protein Structure, Dynamics and Function

Few tools have changed structural biology as quickly as AlphaFold2. Within a few years of its release, AlphaFold2 had become an important starting point for structural studies of many proteins. However, transporters, receptors, channels and many enzymes function through conformational changes, and ligand binding can shift proteins between different structural states. A single predicted model, however confident, represents one structural state rather than the full range of conformations a protein may populate. This is where Electron Paramagnetic Resonance (EPR) spectroscopy comes in.

Read article
AlphaFold and EPR Spectroscopy: Complementary Tools for Understanding Protein Structure, Dynamics and Function